States Say Ruling In Other Mifepristone Case Supports Their Standing Argument

( April 14, 2026, 2:52 PM EDT) -- ST. LOUIS — Missouri, Idaho and Kansas, which are challenging the U.S. Food and Drug Administration’s approval of mifepristone XE "mifepristone" , one of two drugs used to induce early termination of pregnancy, point to a recent decision by a Louisiana federal court that granted the FDA’s motion to stay all proceedings in that case but also found that the state had standing....

Attached Documents

Related Sections